Rockland Trust’s Medpace MEDP Stock Holding History

Rockland Trust’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-750	Closed	-$309K	–	298
2024 Q2	$309K	Hold	750	–	–	0.02%	244
2024 Q1	$303K	Hold	750	–	–	0.02%	247
2023 Q4	$230K	Buy	+750	New	+$202K	0.01%	269

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rockland Trust's MEDP Position: Q3 2024 in Review

Rockland Trust sold out of Medpace (MEDP) in Q3 2024, closing a stake of 750 shares — an estimated $309K sold.

Rockland Trust first reported a position in MEDP in Q4 2023 and held it in 3 quarters. The position peaked at $309K in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

Rockland Trust reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
Rockland Trust sold 750 Medpace shares in Q3 2024, an estimated $309K.
Rockland Trust first reported a position in Medpace in Q4 2023 and held it in 3 quarters.
Rockland Trust's Medpace position peaked at $309K in Q2 2024.
583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Rockland Trust's 13F filing for Q3 2024, filed 3 Oct 2024.